摘要
目的观察黛力新治疗慢性胃炎伴焦虑抑郁症状患者的疗效。方法将60例慢性胃炎并焦虑和/或抑郁的患者随机分成黛力新组(30例)和对照组(30例)。治疗前、治疗4周后分别进行胃肠道症状和焦虑抑郁症状评分测定。结果黛力新组与治疗前比较HAMA和HAMD评分明显降低(P<0.05),与对照组比较,治疗后组间差异有显著性(P<0.05);黛力新组胃肠道症状总有效率与对照组比较有显著差异(P<0.05)。结论黛力新能改善慢性胃炎患者的胃肠道和焦虑抑郁症状,可提高患者的临床疗效和生活质量。
Objective To observe the therapeutic effect of Dailixin on chronic gastritis patients with anxiety-depres- sion. Methods Using randomized （1：1） controlled trails to divide the 60 chronic gastritis patients with anxiety and or depression to the Dailixin group （30 cases） and control group （30 cases）. Pre-treatment and post-treatment, respective- ly finished the tests of the sign and symptom of gastrointestinal disease and anxiety-depression score. Results for Dail- ixin group, comparing pre-treatment, the score of HAMA and HAMD had remarkable decrease （P 〈 0.05）; In compari- son to the score of control group, treatment group had significant effect （P 〈 0.05）. To control the gastrointestinal symptom of chronic gastritis, the effective rate of Dailixin group had remarkable effect （P 〈 0.05）. Conclusion Dailixin has an effect on gastrointestinal symptom and anxiety-depression to chronic gastritis patients with anxiety and/or de- pression, at the same time Dailixin improves the clinical effects and the quality of daily life.
出处
《中国现代医生》
2013年第34期73-74,共2页
China Modern Doctor
关键词
黛力新
慢性胃炎
焦虑抑郁
Dailixin
Chronic gastritis
Anxiety-depression
